238. ビタミンＤ抵抗性くる病/骨軟化症 Vitamin D-resistant rickets Clinical trials / Disease details
臨床試験数 : 29 / 薬物数 : 25 - (DrugBank : 11) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04045834 (ClinicalTrials.gov) | May 5, 2019 | 4/8/2019 | Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia | Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia | PET / CT;PET / MR;Neuroendocrine Tumors;Osteomalacia | Device: 68Ga-DOTA-TATE PET/MR and PET/CT imaging | Wuhan Union Hospital, China | NULL | Recruiting | 20 Years | 80 Years | All | 60 | China | |
| 2 | NCT03736564 (ClinicalTrials.gov) | January 31, 2019 | 30/10/2018 | Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia | 68Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia | Osteomalacia | Combination Product: 68Ga-DOTATATE PET/CT | Mayo Clinic | NULL | Recruiting | 18 Years | N/A | All | 10 | Phase 1/Phase 2 | United States |